Gastric Electric Stimulators Market

By Type;

Low Frequency Gastric Electrical Stimulators and High Frequency Gastric Electrical Stimulator

By Indication;

Refractory Nausea, Gastroparesis, Obesity, and Others

By Application;

Gastroparesis and Obesity

By End User;

Hospitals, Clinics, and Ambulatory Surgical Centers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn969088457 Published Date: June, 2025 Updated Date: July, 2025

Gastric Electric Stimulators Market Overview

Gastric Electric Stimulators Market (USD Million)

Gastric Electric Stimulators Market was valued at USD 175.80 million in the year 2024. The size of this market is expected to increase to USD 276.80 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.7%.


Gastric Electric Stimulators Market

*Market size in USD million

CAGR 6.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.7 %
Market Size (2024)USD 175.80 Million
Market Size (2031)USD 276.80 Million
Market ConcentrationMedium
Report Pages375
175.80
2024
276.80
2031

Major Players

  • Medtronic Plc
  • IntraPace Inc
  • ReShape Lifesciences Inc
  • Changzhou Ruishen Medical Equipment Co. Ltd
  • MetaCure
  • Rishena Co Ltd
  • EnteroMedics

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Gastric Electric Stimulators Market

Fragmented - Highly competitive market without dominant players


The Gastric Electric Stimulators Market is experiencing significant traction, driven by rising adoption of advanced neuromodulation technologies. Over 60% of healthcare professionals are turning to these devices for more effective treatment of gastric motility disorders. Continuous innovation in minimally invasive procedures and upgrades in programmable stimulators are opening new growth opportunities across the healthcare landscape.

Expanding Demand for Personalized Treatments
With more than 55% of clinicians supporting personalized electric stimulation therapies, the market is rapidly evolving. Patients unresponsive to traditional treatments are benefiting from these targeted interventions, prompting strategies focused on innovation and partnerships. Ongoing collaborative developments are enhancing treatment precision and device customization, making the segment highly attractive for further investment.

Smart Technologies Driving Device Advancements
The adoption of AI-based platforms and wireless technology in over 65% of new devices marks a shift toward intelligent, real-time treatment systems. These technological advancements allow for precise monitoring and more personalized therapy. This evolution is reshaping the future outlook, as remote functionality and smart analytics become key drivers of success in this segment.

Sustained Growth with Focused Investment
With more than 58% of healthcare organizations incorporating these devices into routine care, the market is positioned for sustained growth and innovation. Improved reimbursement models and dedicated R&D investments are accelerating the pace of expansion. As more companies explore strategic pathways, the Gastric Electric Stimulators Market is set to transform gastrointestinal therapy through targeted, data-driven stimulation technologies.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Gastric Electric Stimulators Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Gastroparesis and Other Gastric Disorders
        2. Technological Advancements
        3. Growing Acceptance of Neuromodulation Therapies
      2. Restraints
        1. High Cost of Treatment
        2. Risk of Adverse Events
        3. Regulatory Challenges
      3. Opportunities
        1. Untapped Emerging Markets
        2. Expansion into New Indications
        3. Personalized Medicine and Precision Therapy
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Gastric Electric Stimulators Market, By Product Type, 2021 - 2031 (USD Million)
      1. Low Frequency Gastric Electrical Stimulators
      2. High Frequency Gastric Electrical Stimulator
    2. Gastric Electric Stimulators Market, By Indication, 2021 - 2031 (USD Million)
      1. Refractory Nausea
      2. Gastroparesis
      3. Obesity
      4. Others
    3. Gastric Electric Stimulators Market, By Application, 2021 - 2031 (USD Million)

      1. Gastroparesis

      2. Obesity

    4. Gastric Electric Stimulators Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
    5. Gastric Electric Stimulators Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic Plc
      2. IntraPace Inc
      3. ReShape Lifesciences Inc
      4. Changzhou Ruishen Medical Equipment Co. Ltd
      5. MetaCure
      6. Rishena Co Ltd
      7. EnteroMedics
  7. Analyst Views
  8. Future Outlook of the Market